Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H17NO2 |
| Molecular Weight | 291.3438 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1=C2C=C(C)C=CC2=NC(=C1)C3=CC=CC=C3
InChI
InChIKey=BUDBHJPMAKXMLD-UHFFFAOYSA-N
InChI=1S/C19H17NO2/c1-3-22-19(21)16-12-18(14-7-5-4-6-8-14)20-17-10-9-13(2)11-15(16)17/h4-12H,3H2,1-2H3
| Molecular Formula | C19H17NO2 |
| Molecular Weight | 291.3438 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Neocinchophen is an analgesic and uricosuric. Cinchophen and neocinchophen (introduced by Chemische Fabrik auf Aktien as Atophan and Novatophan) were being advertised as superior substitutes for salicylates in the treatment of rheumatic fever. Chemically, cinchophen is phenylcinchoninic acid,
and neocinchophen is the ethyl ester of its methyl derivative.
Originator
Approval Year
Sample Use Guides
Rheumatic fever: Neocinchophen was administered in
tablet form, 1 g of the drug being used every hour
until definite symptoms of drug action were manifested. The three patients with rheumatic fever
that were treated with neocinchophen obtained complete relief from subjective and objective symptoms of the disease after doses of 11, 14 and 16 g. One patient received with impunity 15 g additional to the 11 g, which gave him complete relief.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:18:17 GMT 2025
by
admin
on
Mon Mar 31 18:18:17 GMT 2025
|
| Record UNII |
539M941Y9O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
||
|
NCI_THESAURUS |
C921
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB09194MIG
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
4159
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
C75068
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
68089
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
539M941Y9O
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
34910
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
CHEMBL1370602
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
100000084153
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
207-615-5
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
DTXSID2046250
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY | |||
|
485-34-7
Created by
admin on Mon Mar 31 18:18:17 GMT 2025 , Edited by admin on Mon Mar 31 18:18:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |